Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

CDC-Authored Genomics and Precision Health Publications Database|Home|PHGKB

CDC-Authored Genomics and Precision Health Publications Database


Last data update: Mar 30, 2023. (Total: 4251 publications since 2011)
   dataset
Filtered By:
Records 1-7 (of 7 Records)
Query Trace: all>>Suzanne R Kalb[CDC Author]
Characterization of Hemagglutinin Negative Botulinum Progenitor Toxins.
Suzanne R Kalb, Jakub Baudys, Theresa J Smith, Leonard A Smith, and John R Barr
Toxins 2017 Jun 9(6)
Engineering Botulinum Neurotoxin C1 as a Molecular Vehicle for Intra-Neuronal Drug Delivery.
Edwin J Vazquez-Cintron, Phillip H Beske, Luis Tenezaca, Bao Q Tran, Jonathan M Oyler, Elliot J Glotfelty, Christopher A Angeles, Aurelia Syngkon, Jean Mukherjee, Suzanne R Kalb, Philip A Band, Patrick M McNutt, Charles B Shoemaker, and Konstantin Ichtchenko
Scientific reports 2017 Feb 742923
Purification and Characterization of Botulinum Neurotoxin FA from a Genetically Modified Clostridium botulinum Strain.
Sabine Pellett, William H Tepp, Marite Bradshaw, Suzanne R Kalb, Janet K Dykes, Guangyun Lin, Erin M Nawrocki, Christina L Pier, John R Barr, Susan E Maslanka, and Eric A Johnson
mSphere 1(1)
A Novel Botulinum Toxin, Previously Reported as Serotype H, has a Hybrid Structure of Known Serotypes A and F that is Neutralized with Serotype A Antitoxin.
Susan E Maslanka, Carolina Lúquez, Janet K Dykes, William H Tepp, Christina L Pier, Sabine Pellett, Brian H Raphael, Suzanne R Kalb, John R Barr, Agam Rao, and Eric A Johnson
J. Infect. Dis. 2015 Jun 10.
Isolation and functional characterization of the novel Clostridium botulinum neurotoxin A8 subtype.
Skadi Kull, K Melanie Schulz, Jasmin Weisemann, Sebastian Kirchner, Tanja Schreiber, Alexander Bollenbach, P Wojtek Dabrowski, Andreas Nitsche, Suzanne R Kalb, Martin B Dorner, John R Barr, Andreas Rummel, and Brigitte G Dorner
PLoS ONE 2015 10(2) e0116381
Clostridium botulinum strains producing BoNT/F4 or BoNT/F5.
Brian H Raphael, Marite Bradshaw, Suzanne R Kalb, Lavin A Joseph, Carolina Lúquez, John R Barr, Eric A Johnson, and Susan E Maslanka
Appl. Environ. Microbiol. 2014 May 80(10) 3250-7
Discovery of a novel enzymatic cleavage site for botulinum neurotoxin F5.
Suzanne R Kalb, Jakub Baudys, Robert P Webb, Patrick Wright, Theresa J Smith, Leonard A Smith, Rafael Fernández, Brian H Raphael, Susan E Maslanka, James L Pirkle, and John R Barr
FEBS letters 2012 Jan 586(2) 109-15
TOP